Sweeney, Timothy E.
Inflammatix, Inc.,
United States
2025 Rank: 228601
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Emergency & Critical Care Medicine
SubField 2:
Developmental Biology
Rank in SubField 1: 656 out of 41816 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 228601 | 206978 |
| Total Cites | 443 | 528 |
| H-index | 10 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 155 | 175 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 198 | 226 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 355 | 388 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.36 |
| Self-Citation Percentage |
16.10%
|
|
Sweeney, Timothy E.
Inflammatix Inc.,
United States
2024 Rank: 160048
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Emergency & Critical Care Medicine
SubField 2:
Developmental Biology
Rank in SubField 1: 505 out of 39519 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 160048 | 153255 |
| Total Cites | 456 | 544 |
| H-index | 12 | 13 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 177 | 196 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 222 | 253 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 350 | 385 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.41 |
| Self-Citation Percentage |
16.18%
|
|
Sweeney, Timothy E.
Inflammatix, Inc.,
United States
2023 Rank: 150514
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Emergency & Critical Care Medicine
SubField 2:
Immunology
Rank in SubField 1: 510 out of 37023 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 150514 | 120706 |
| Total Cites | 458 | 591 |
| H-index | 14 | 16 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 210 | 259 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 251 | 318 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 356 | 389 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.52 |
| Self-Citation Percentage |
22.50%
|
|
Sweeney, Timothy E.
Inflammatix, Inc.,
United States
2022 Rank: 113702
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Emergency & Critical Care Medicine
SubField 2:
Developmental Biology
Rank in SubField 1: 387 out of 34180 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 113702 | 93766 |
| Total Cites | 409 | 535 |
| H-index | 11 | 12 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 229 | 301 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 258 | 345 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 329 | 362 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.48 |
| Self-Citation Percentage |
23.55%
|
|
Sweeney, Timothy E.
Inflammatix,
United States
2021 Rank: 142672
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Emergency & Critical Care Medicine
SubField 2:
Immunology
Rank in SubField 1: 462 out of 31838 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 142672 | 123158 |
| Total Cites | 546 | 674 |
| H-index | 13 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 297 | 376 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 311 | 401 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 436 | 467 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.44 |
| Self-Citation Percentage |
18.99%
|
|
Sweeney, Timothy E.
Inflammatix, Inc,
United States
2020 Rank: 151949
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Emergency & Critical Care Medicine
SubField 2:
Immunology
Rank in SubField 1: 479 out of 28564 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 151949 | 142509 |
| Total Cites | 407 | 484 |
| H-index | 11 | 13 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 245 | 296 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 245 | 296 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 329 | 354 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.37 |
| Self-Citation Percentage |
15.91%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.